The Current Ratio as of October 2024 (TTM) for Merrimack Pharmaceuticals, Inc. (MACK) is 10.78

According to Merrimack Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.78. This represents a change of -69.37% compared to the average of 35.18 of the last 4 quarters.

Merrimack Pharmaceuticals, Inc. (MACK) Historical Current Ratio (quarterly & annually)

How has MACK Current Ratio performed in the past?

The mean historical Current Ratio of Merrimack Pharmaceuticals, Inc. over the last ten years is 14.53. The current 10.78 Current Ratio has changed 7.32% with respect to the historical average. Over the past ten years (40 quarters), MACK's Current Ratio was at its highest in in the June 2023 quarter at 47.30. The Current Ratio was at its lowest in in the March 2017 quarter at 0.43.

Merrimack Pharmaceuticals, Inc. (MACK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Merrimack Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Merrimack Pharmaceuticals, Inc. (MACK) Average Current Ratio

How has MACK Current Ratio performed in the past?

The current Current Ratio of Merrimack Pharmaceuticals, Inc. (MACK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Merrimack Pharmaceuticals, Inc. (MACK) Current Ratio vs. Peers

How is MACK’s Current Ratio compared to its peers?

Merrimack Pharmaceuticals, Inc.’s Current Ratio is greater than Amicus Therapeutics, Inc. (2.75), less than Celldex Therapeutics, Inc. (29.36), greater than Achison Inc. (0.52), greater than Puma Biotechnology, Inc. (1.32), greater than Agios Pharmaceuticals, Inc. (8.99),

Build a custom stock screener for Merrimack Pharmaceuticals, Inc. (MACK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Merrimack Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Merrimack Pharmaceuticals, Inc. (MACK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Merrimack Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.